| Accession |
PRJCA013396 |
| Title |
SHR-1210-II-215 An open, multicenter phase II trial of carrilizumab combined with malate famitinib in the treatment of advanced solid tumors. |
| Relevance |
Medical |
| Data types |
clinical information,imaging,biomarker data,etc
|
| Organisms |
Homo sapiens
|
| Description |
SHR-1210-II-215clinical information,imaging data, biomarker data,etc. |
| Sample scope |
Monoisolate |
| Release date |
2022-11-22 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
NA
|
|
|
| Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2022-11-22 |
